NIMH Clinical Trials

The information found on our Clinical Trial Requirements for Grants and Contracts pages applies across all NIH institutes, centers, and offices (ICOs). This page provides NIMH interest areas, types of trials supported, and other funding considerations related to Clinical Trials.

Clinical Trials Interest Areas

Clinical Trials Focused on Efficacy, Effectiveness, and/or Safety 

NIMH prioritizes an experimental therapeutics approach for the development and testing of therapeutic, preventive, and services interventions, in which the studies not only evaluate the clinical effect of the intervention on outcomes of interest, but also interrogates the hypothesized change in mechanisms presumed to account for intervention outcomes of interest, and/or account for intervention benefit. Accordingly, NIMH prioritizes applications that address: 

(1) the empirical basis for the selection of intervention targets, 

(2) plans for assessing whether the intervention engages the presumed targets, and 

(3) analytic plans to examine whether the intervention-induced changes in targets map to clinical changes.

For first-in-human and first-in-pediatric trials with pharmacokinetic and pharmacodynamic readouts, NIMH prioritizes early-stage dose response trials that use objective measures of central nervous system function to establish dosing for subsequent efficacy trials. 

Applicants who propose studies that focus on establishing or testing efficacy, effectiveness, and/or safety (as above) are encouraged to apply under NIMH Clinical Trials NOFOs. 

Biomarker studies

NIMH prioritizes development of biomarkers such as radioligands, EEG markers, digital, and voice and speech measures in preclinical (cross-species) and human studies (e.g., healthy human and patients with mental illnesses) to facilitate their validation for inclusion in clinical trials.

Clinical Trials Contacts

Potential applicants are strongly encouraged to contact the Scientific/Research contact to discuss the alignment with current NIMH priorities.

Please include ‘clinical trial inquiry’ in the email subject line and attach project draft aims, as relevant, to facilitate a response to your inquiry.

NIMH Referral Office
[email protected]

Scientific Program Contact

Division of AIDS Research
[email protected] 

Division of Data Science and Technology
[email protected] 

Center for Global Mental Health Research
[email protected] 

Division of Neuroscience and Basic Behavioral Science
[email protected] 

Division of Services and Intervention Research
[email protected] 

Division of Translational Research
[email protected] 

NIMH Small Business Program
[email protected]  


For technical issues E-mail OER Webmaster